Latest AI and machine learning research in oncology/hematology for healthcare professionals.
BACKGROUND: Ovarian cancer has the highest mortality rate among gynecological cancers, making early ...
PURPOSE: High-grade clear cell renal cell carcinoma (ccRCC) is linked to lower survival rates and mo...
OBJECTIVE: To develop an interpretable machine learning (ML) model using dynamic contrast-enhanced m...
Calculation of tumor cell percentage, a critical pre-analytical component in molecular pathology, is...
Nuclei segmentation is the first stage of automated microscopic image analysis. The cell nucleus is...
Accurate preoperative prediction of biochemical recurrence (BCR) in prostate cancer (PCa) is essenti...
The preoperative human epidermal growth factor receptor type 2 (HER2) status of breast cancer is typ...
BACKGROUND: Ovarian cancer is among the most lethal malignancies in women. The advent of PARP inhibi...
Lung cancer remains the leading cause of cancer-related deaths worldwide. Low-dose computed tomograp...
BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is the predominant subtype of renal cancer, with...
INTRODUCTION: Gastrointestinal disorders (GIDs) affect nearly 40% of the global population, with gut...
Data scieQuerynce (DS) methods and artificial intelligence (AI) are critical in today's healthcare s...
Breast cancer survival is hard to predict because of the complex ways genes and cells interact. This...
BACKGROUND AND PURPOSE: Despite the widespread research application of radiomics, there is a knowled...
BACKGROUND: Individuals with triple-negative breast cancer (TNBC) exhibit elevated lactate levels, w...
Drug co-assemblies have attracted extensive attention due to their advantages of easy preparation, a...
SIGNIFICANCE: Diffuse correlation tomography (DCT) is an emerging technique for the noninvasive meas...
BACKGROUND AND PURPOSE: Proton therapy requires dose monitoring, often performed based on repeated c...
BACKGROUND: Ferroptosis, an iron-dependent form of regulated cell death, has garnered significant at...
PURPOSE: To develop and validate a predictor for early treatment response in hepatocellular carcinom...